NCT06011694

The Jinling Cohort

A Prospective, Multicenter Cohort Study of the Multi-omics Liquid Biopsy MCED Test MERCURY in an Average Risk Chinese Population

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 15,000 (estimated)
• Sponsor: Nanjing Shihejiyin Technology, Inc. · Industry
• Sex: All
• Age: 45 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.

Detailed description

Its aim is to assess the performance and clinical utility of the Multi-omics liquid biopsy MCED test MERCURY in an average risk Chinese population. Each participant will undergo peripheral blood collection for MERCURY test, health questionnaires and annual routine physical exams once a year for three consecutive years, then followed up two additional years. The entire assess time is 60 months. The primary goals of the study is to evaluate sensitivity, specificity, positive/negative predictive value and other performance of MERCURY test. The secondary goal of the study is (1) to evaluate how many cancer types the test MERCURY can detect and TOO accuracy; (2) With MCED test and routine physical exams being conducted in parallel for three years and following up for five years, the study allows to assess MERCURY test can detect cancer how many years earlier than conventional methods, leading to its clinical value evaluation of whether it can ensure reduction in late-stage cancer diagnosis; (3) to evaluate participants' attitude and perception towards MCED blood test.

Conditions

• Cancer
• Multi Cancer Early Screening
• Liquid Biopsy

Interventions

Type	Name	Description
OTHER	MERCURY test, health questionnaires and annual routine physical exams	Each participant will undergo peripheral blood collection for MERCURY test, health questionnaires and annual routine physical exams once a year for three consecutive years, then followed up two additional years.

Timeline

• Start date: 2022-06-15
• Primary completion: 2027-05-15
• Completion: 2027-05-15
• First posted: 2023-08-25
• Last updated: 2023-08-25

Locations

2 sites across 1 country: China